Cancers · 2024 · 32 citations · 72 references
PharmacyOncologyPharmacologyCancer PharmacologyDrug DiscoveryDrug RepurposingCombination Therapy RepurposingComputational Drug RepurposingDrug DevelopmentMechanism-based RepurposingAnticancer RepurposingChemoinformatics-based RepurposingDrug Repurposing In CancerMolecular Drug ResistancePharmaceutical Innovation StrategyRepurposing Candidate PrioritizationRepurposing Of Approved DrugsTreatment Strategies
Cancer persists as a global challenge necessitating continual innovation in treatment strategies. Despite significant advancements in comprehending the disease, cancer remains a leading cause of mortality worldwide, exerting substantial economic burdens on healthcare systems and societies. The emergence of drug resistance further complicates therapeutic efficacy, underscoring the urgent need for alternative approaches. Drug repurposing, characterized by the utilization of existing drugs for novel clinical applications, emerges as a promising avenue for addressing these challenges. Repurposed drugs, comprising FDA-approved (in other disease indications), generic, off-patent, and failed medications, offer distinct advantages including established safety profiles, cost-effectiveness, and expedited development timelines compared to novel drug discovery processes. Various methodologies, such as knowledge-based analyses, drug-centric strategies, and computational approaches, play pivotal roles in identifying potential candidates for repurposing. However, despite the promise of repurposed drugs, drug repositioning confronts formidable obstacles. Patenting issues, financial constraints associated with conducting extensive clinical trials, and the necessity for combination therapies to overcome the limitations of monotherapy pose significant challenges. This review provides an in-depth exploration of drug repurposing, covering a diverse array of approaches including experimental, re-engineering protein, nanotechnology, and computational methods. Each of these avenues presents distinct opportunities and obstacles in the pursuit of identifying novel clinical uses for established drugs. By examining the multifaceted landscape of drug repurposing, this review aims to offer comprehensive insights into its potential to transform cancer therapeutics.
72
Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations
Medicine, Oncology, Pharmacology +16
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Steven M. Corsello, Rohith T. Nagari, Ryan D. Spangler et al. · Nature Cancer · 2020 · 883 citations · Full text
Medicine, Oncology, Pharmacology +13
Can you teach old drugs new tricks?
Nicola Nosengo · Nature · 2016 · 731 citations · Full text
Exploiting machine learning for end-to-end drug discovery and development
Sean Ekins, Ana C. Puhl, Kimberley M. Zorn et al. · Nature Materials · 2019 · 566 citations · Full text